We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Guided Mammogram Triage Speeds Same-Day Breast Cancer Workup

By MedImaging International staff writers
Posted on 10 Jun 2026
Image: An open-source AI model stratifies risk directly from screening mammograms, moving high-risk patients to targeted diagnostic imaging and, when indicated, same-day biopsy (image credit: Adobe Stock)
Image: An open-source AI model stratifies risk directly from screening mammograms, moving high-risk patients to targeted diagnostic imaging and, when indicated, same-day biopsy (image credit: Adobe Stock)

Abnormal findings on screening mammograms can leave women waiting weeks for answers, prolonging anxiety and delaying care. These delays can strain diagnostic services, particularly in safety-net hospitals, and postpone biopsies for patients who ultimately have cancer. A newly introduced artificial intelligence (AI)–guided triage workflow prioritizes patients most likely to have disease for immediate workup. Researchers have now shown that this approach can shorten the diagnostic pathway to a single day for selected high-risk patients..

Investigators at the University of California, San Francisco (UCSF) and the University of California, Berkeley used Mirai, an open-source AI model, to stratify risk directly from screening mammograms. Launched at Zuckerberg San Francisco General Hospital and Trauma Center, the program moves high-risk patients from screening to targeted diagnostic imaging and, when indicated, to biopsy on the same day.

Mirai was trained on hundreds of thousands of mammograms paired with cancer outcomes to recognize subtle patterns on screening studies and estimate near‑term risk. Clinicians then use that score to triage patients for accelerated evaluation without replacing radiologist interpretation or making autonomous diagnoses. The intent is to direct limited same‑day diagnostic capacity to those most likely to benefit.

Before deployment, the team analyzed more than 114,000 archival mammograms to tune thresholds that would capture enough high‑risk cases without overwhelming the clinic. In prospective use on more than 4,100 screening mammograms, Mirai designated 525 women, or 12.7%, as high risk. Those patients received immediate readouts and same‑day diagnostic imaging for suspicious findings, and some underwent biopsy the same day.

The approach shortened the wait for diagnostic evaluation from several weeks to about an hour. Among women ultimately diagnosed with breast cancer, the average time to biopsy dropped from more than two months to fewer than 10 days. Findings were published in npj Digital Medicine in Msy 18, 2026, with contributions from UCSF and UC Berkeley.

“This is really an exciting time. This moves us closer to personalized care, where we can tailor a plan so that each patient gets the right intervention at the right time,” said Maggie Chung, MD, first author of the study.

“This is a powerful example of how AI can be a collaborative partner for physicians. It shows how we can improve care when we bring clinicians and data scientists together to design these systems,” said Adam Yala, Ph.D., assistant professor in the UCSF‑UC Berkeley Joint Program in Computational Precision Health.

Related Links
UCSF
UCSF‑UC Berkeley Joint Program in Computational Precision Health

Post-Processing Imaging System
DynaCAD Prostate
Digital Color Doppler Ultrasound System
MS22Plus
Portable X-ray Unit
AJEX140H
Ultrasound Needle Guidance System
SonoSite L25

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.